JP2018054620A5 - - Google Patents

Download PDF

Info

Publication number
JP2018054620A5
JP2018054620A5 JP2017216846A JP2017216846A JP2018054620A5 JP 2018054620 A5 JP2018054620 A5 JP 2018054620A5 JP 2017216846 A JP2017216846 A JP 2017216846A JP 2017216846 A JP2017216846 A JP 2017216846A JP 2018054620 A5 JP2018054620 A5 JP 2018054620A5
Authority
JP
Japan
Prior art keywords
biomarker
level
sample
pick disease
positive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017216846A
Other languages
English (en)
Japanese (ja)
Other versions
JP6711807B2 (ja
JP2018054620A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018054620A publication Critical patent/JP2018054620A/ja
Publication of JP2018054620A5 publication Critical patent/JP2018054620A5/ja
Application granted granted Critical
Publication of JP6711807B2 publication Critical patent/JP6711807B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017216846A 2011-11-15 2017-11-10 ニーマン・ピック病の診断のための方法 Expired - Fee Related JP6711807B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11009062 2011-11-15
EP11009062.8 2011-11-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014541566A Division JP6243846B2 (ja) 2011-11-15 2012-11-15 ニーマン・ピック病の診断のための方法

Publications (3)

Publication Number Publication Date
JP2018054620A JP2018054620A (ja) 2018-04-05
JP2018054620A5 true JP2018054620A5 (cg-RX-API-DMAC10.html) 2018-06-07
JP6711807B2 JP6711807B2 (ja) 2020-06-17

Family

ID=47221301

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014541566A Expired - Fee Related JP6243846B2 (ja) 2011-11-15 2012-11-15 ニーマン・ピック病の診断のための方法
JP2017216846A Expired - Fee Related JP6711807B2 (ja) 2011-11-15 2017-11-10 ニーマン・ピック病の診断のための方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014541566A Expired - Fee Related JP6243846B2 (ja) 2011-11-15 2012-11-15 ニーマン・ピック病の診断のための方法

Country Status (11)

Country Link
US (4) US9910033B2 (cg-RX-API-DMAC10.html)
EP (1) EP2780716B1 (cg-RX-API-DMAC10.html)
JP (2) JP6243846B2 (cg-RX-API-DMAC10.html)
AU (3) AU2012339149A1 (cg-RX-API-DMAC10.html)
BR (1) BR112014009223B1 (cg-RX-API-DMAC10.html)
CA (1) CA2854668A1 (cg-RX-API-DMAC10.html)
CY (1) CY1122360T1 (cg-RX-API-DMAC10.html)
DK (1) DK2780716T3 (cg-RX-API-DMAC10.html)
IL (1) IL231982B (cg-RX-API-DMAC10.html)
MX (2) MX359328B (cg-RX-API-DMAC10.html)
WO (1) WO2013072060A2 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014153083A1 (en) 2013-03-14 2014-09-25 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect
MX370570B (es) 2013-06-07 2019-12-17 Genzyme Corp Marcador para trastornos de la esfingomielinasa acida y sus usos.
CA3002526A1 (en) 2014-10-28 2016-05-06 Washington University Bile acid biomarkers for niemann-pick diseases, methods and uses therefor
US20180348239A1 (en) * 2014-11-19 2018-12-06 Centogene Ag Method for the Diagnosis of Niemann-Pick Disease Using a Biomarker
US10656059B2 (en) 2018-03-07 2020-05-19 Alcala Pharmaceutical, Inc. Method for qualitative and quantitative multiplexing of drug analytes from biological samples
US20190369113A1 (en) * 2018-06-01 2019-12-05 Laboratory Corporation Of America Holdings Simplified Biosample Processing for LC-MS/MS
CN111289647A (zh) * 2020-03-09 2020-06-16 广州市妇女儿童医疗中心（广州市妇幼保健院、广州市儿童医院、广州市妇婴医院、广州市妇幼保健计划生育服务中心） 葡糖鞘氨醇的检测方法
WO2024026390A2 (en) * 2022-07-28 2024-02-01 Wylder Nation Foundation Compositions and methods for diagnosing, treating, and preventing lysosomal storage diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4498918B2 (ja) * 2002-04-30 2010-07-07 生化学工業株式会社 リソソーム病の検出方法
US8497122B2 (en) * 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
US8313949B2 (en) * 2009-04-16 2012-11-20 Nextcea Inc. Detecting phospholipidosis and diagnosing lysosomal storage disorders
CA2773133A1 (en) 2009-08-28 2011-03-03 Edward H. Schuchman Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency

Similar Documents

Publication Publication Date Title
Pappireddi et al. A review on quantitative multiplexed proteomics
Bai et al. Integrative analyses reveal transcriptome-proteome correlation in biological pathways and secondary metabolism clusters in A. flavus in response to temperature
Cakmak et al. The prognostic value of circulating microRNAs in heart failure: preliminary results from a genome-wide expression study
US8160819B2 (en) Rapid identification of proteins and their corresponding source organisms by gas phase fragmentation and identification of protein biomarkers
Glasner et al. Label-free, direct localization and relative quantitation of the RNA nucleobase methylations m6A, m5C, m3U, and m5U by top-down mass spectrometry
CA2913016C (en) Antibiotic resistance determination by mass spectrometric measurement of microbial growth
Thomas et al. Mass spectrometry of RNA
Xu et al. Quantification of microRNA by DNA–peptide probe and liquid chromatography–tandem mass spectrometry-based quasi-targeted proteomics
Park et al. Plant metabolomics for plant chemical responses to belowground community change by climate change
JP2014533367A5 (cg-RX-API-DMAC10.html)
Hoyle et al. High resolution mass spectrometry of respiratory viruses: beyond MALDI-ToF instruments for next generation viral typing, subtyping, variant and sub-variant identification
Demirev et al. Applications of mass spectrometry in microbiology
US11339441B2 (en) Profiling chemically modified DNA/RNA units for disease and cancer diagnosis
Waghmare et al. Characterization and quantification of RNA post-transcriptional modifications using stable isotope labeling of RNA in conjunction with mass spectrometry analysis
Beverly Applications of mass spectrometry to the study of siRNA
Carpentier et al. Proteome analysis of orphan plant species, fact or fiction?
Dederko et al. MALDI-TOF MS technique as a new approach for simultaneous detection and differentiation of potato virus Y strains
Krivos et al. Removal of 3'‐phosphate group by bacterial alkaline phosphatase improves oligonucleotide sequence coverage of RNase digestion products analyzed by collision‐induced dissociation mass spectrometry
JP2018196371A (ja) 脱離イオン化に向けた質量分光試料支持部上への生体細胞の準備
JP2016522406A5 (cg-RX-API-DMAC10.html)
Polo et al. Analysis of oligonucleotides by electrospray ionization mass spectrometry
Ahn et al. Arginine‐mimic labeling with guanidinoethanethiol to increase mass sensitivity of lysine‐terminated phosphopeptides by matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry
Gut Depurination of DNA and matrix-assisted laser desorption/ionization mass spectrometry
CN102199672B (zh) 一种检测虫媒脑炎病毒的新技术
Xu et al. Investigation of double‐stranded DNA/drug interaction by ESI/FT ICR: orientation of dissociations relates to stabilizing salt bridges